Getinge AB (publ) Logo

Getinge AB (publ)

GETI-B.ST

(2.5)
Stock Price

227,20 SEK

8.8% ROA

7.82% ROE

27.64x PER

Market Cap.

60.746.519.002,00 SEK

21.48% DER

1.86% Yield

7.58% NPM

Getinge AB (publ) Stock Analysis

Getinge AB (publ) Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Getinge AB (publ) Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (21%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

3 ROE

The stock's ROE falls within an average range (7.3%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (8.8%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 PBV

The stock's PBV ratio (1.88x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

7 Dividend Growth

The company's dividend growth has been consistently strong over the past three years, with annual increases that demonstrate its commitment to rewarding shareholders.

8 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (4.330) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

10 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

11 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

Getinge AB (publ) Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Getinge AB (publ) Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Getinge AB (publ) Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Getinge AB (publ) Revenue
Year Revenue Growth
2002 8.640.100.000
2003 9.160.200.000 5.68%
2004 10.888.800.000 15.88%
2005 11.880.400.000 8.35%
2006 13.001.000.000 8.62%
2007 16.445.000.000 20.94%
2008 19.272.000.000 14.67%
2009 22.816.000.000 15.53%
2010 22.172.000.000 -2.9%
2011 21.854.000.000 -1.46%
2012 24.248.000.000 9.87%
2013 25.287.000.000 4.11%
2014 26.669.000.000 5.18%
2015 30.235.000.000 11.79%
2016 29.756.000.000 -1.61%
2017 22.495.000.000 -32.28%
2018 24.172.000.000 6.94%
2019 26.559.000.000 8.99%
2020 29.819.000.000 10.93%
2021 27.049.000.000 -10.24%
2022 28.291.000.000 4.39%
2023 30.428.000.000 7.02%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Getinge AB (publ) Research and Development Expenses
Year Research and Development Expenses Growth
2002 248.200.000
2003 209.500.000 -18.47%
2004 266.500.000 21.39%
2005 246.100.000 -8.29%
2006 267.000.000 7.83%
2007 316.000.000 15.51%
2008 497.000.000 36.42%
2009 539.000.000 7.79%
2010 441.000.000 -22.22%
2011 540.000.000 18.33%
2012 598.000.000 9.7%
2013 619.000.000 3.39%
2014 597.000.000 -3.69%
2015 598.000.000 0.17%
2016 671.000.000 10.88%
2017 594.000.000 -12.96%
2018 691.000.000 14.04%
2019 762.000.000 9.32%
2020 1.033.000.000 26.23%
2021 851.000.000 -21.39%
2022 1.185.000.000 28.19%
2023 1.124.000.000 -5.43%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Getinge AB (publ) General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 774.300.000
2003 808.600.000 4.24%
2004 -1.111.200.000 172.77%
2005 -1.194.100.000 6.94%
2006 -1.269.000.000 5.9%
2007 -1.379.000.000 7.98%
2008 1.822.000.000 175.69%
2009 2.333.000.000 21.9%
2010 2.355.000.000 0.93%
2011 2.198.000.000 -7.14%
2012 2.405.000.000 8.61%
2013 2.599.000.000 7.46%
2014 2.824.000.000 7.97%
2015 3.300.000.000 14.42%
2016 3.359.000.000 1.76%
2017 2.650.000.000 -26.75%
2018 3.090.000.000 14.24%
2019 3.443.000.000 10.25%
2020 3.498.000.000 1.57%
2021 3.337.000.000 -4.82%
2022 3.516.000.000 5.09%
2023 4.216.000.000 16.6%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Getinge AB (publ) EBITDA
Year EBITDA Growth
2002 -464.000.000
2003 -645.400.000 28.11%
2004 2.033.700.000 131.74%
2005 2.142.400.000 5.07%
2006 2.318.000.000 7.58%
2007 3.243.000.000 28.52%
2008 16.265.000.000 80.06%
2009 3.655.000.000 -345.01%
2010 3.887.000.000 5.97%
2011 4.118.000.000 5.61%
2012 4.206.000.000 2.09%
2013 4.147.000.000 -1.42%
2014 3.836.000.000 -8.11%
2015 3.406.000.000 -12.62%
2016 3.601.000.000 5.42%
2017 4.817.000.000 25.24%
2018 1.602.000.000 -200.69%
2019 4.871.000.000 67.11%
2020 7.380.000.000 34%
2021 6.168.000.000 -19.65%
2022 5.939.000.000 -3.86%
2023 8.388.000.000 29.2%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Getinge AB (publ) Gross Profit
Year Gross Profit Growth
2002 3.815.100.000
2003 4.115.100.000 7.29%
2004 5.058.900.000 18.66%
2005 5.458.400.000 7.32%
2006 6.095.000.000 10.44%
2007 7.939.000.000 23.23%
2008 9.333.000.000 14.94%
2009 11.252.000.000 17.05%
2010 11.371.000.000 1.05%
2011 11.402.000.000 0.27%
2012 12.704.000.000 10.25%
2013 13.124.000.000 3.2%
2014 13.110.000.000 -0.11%
2015 14.163.000.000 7.43%
2016 13.840.000.000 -2.33%
2017 10.602.000.000 -30.54%
2018 11.053.000.000 4.08%
2019 12.455.000.000 11.26%
2020 14.722.000.000 15.4%
2021 13.580.000.000 -8.41%
2022 13.409.000.000 -1.28%
2023 14.364.000.000 6.65%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Getinge AB (publ) Net Profit
Year Net Profit Growth
2002 621.700.000
2003 777.700.000 20.06%
2004 1.147.800.000 32.24%
2005 1.138.400.000 -0.83%
2006 1.254.000.000 9.22%
2007 1.260.000.000 0.48%
2008 1.523.000.000 17.27%
2009 1.914.000.000 20.43%
2010 2.277.000.000 15.94%
2011 2.529.000.000 9.96%
2012 2.521.000.000 -0.32%
2013 2.285.000.000 -10.33%
2014 1.433.000.000 -59.46%
2015 1.390.000.000 -3.09%
2016 1.188.000.000 -17%
2017 1.376.000.000 13.66%
2018 -967.000.000 242.3%
2019 1.222.000.000 179.13%
2020 3.239.000.000 62.27%
2021 2.970.000.000 -9.06%
2022 2.491.000.000 -19.23%
2023 3.576.000.000 30.34%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Getinge AB (publ) Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 3
2003 4 33.33%
2004 5 40%
2005 5 0%
2006 6 0%
2007 6 0%
2008 7 16.67%
2009 8 14.29%
2010 9 22.22%
2011 10 10%
2012 10 -11.11%
2013 9 0%
2014 6 -80%
2015 6 0%
2016 5 -25%
2017 5 20%
2018 -4 266.67%
2019 4 175%
2020 12 63.64%
2021 11 -10%
2022 9 -11.11%
2023 13 30.77%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Getinge AB (publ) Free Cashflow
Year Free Cashflow Growth
2002 1.061.800.000
2003 1.118.700.000 5.09%
2004 647.900.000 -72.67%
2005 777.500.000 16.67%
2006 983.500.000 20.95%
2007 594.000.000 -65.57%
2008 382.000.000 -55.5%
2009 2.844.000.000 86.57%
2010 2.861.000.000 0.59%
2011 2.237.000.000 -27.89%
2012 1.983.000.000 -12.81%
2013 1.861.000.000 -6.56%
2014 2.800.000.000 33.54%
2015 1.710.000.000 -63.74%
2016 2.246.000.000 23.86%
2017 1.100.000.000 -104.18%
2018 1.123.000.000 2.05%
2019 2.612.000.000 57.01%
2020 6.154.000.000 57.56%
2021 5.630.000.000 -9.31%
2022 2.231.000.000 -152.35%
2023 1.068.000.000 -108.9%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Getinge AB (publ) Operating Cashflow
Year Operating Cashflow Growth
2002 1.211.400.000
2003 1.386.100.000 12.6%
2004 1.056.400.000 -31.21%
2005 1.169.300.000 9.66%
2006 1.504.500.000 22.28%
2007 1.328.000.000 -13.29%
2008 1.475.000.000 9.97%
2009 4.000.000.000 63.13%
2010 4.124.000.000 3.01%
2011 3.496.000.000 -17.96%
2012 3.687.000.000 5.18%
2013 3.544.000.000 -4.03%
2014 3.473.000.000 -2.04%
2015 3.458.000.000 -0.43%
2016 3.671.000.000 5.8%
2017 2.763.000.000 -32.86%
2018 2.503.000.000 -10.39%
2019 3.832.000.000 34.68%
2020 7.199.000.000 46.77%
2021 6.560.000.000 -9.74%
2022 3.367.000.000 -94.83%
2023 1.411.000.000 -138.63%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Getinge AB (publ) Capital Expenditure
Year Capital Expenditure Growth
2002 149.600.000
2003 267.400.000 44.05%
2004 408.500.000 34.54%
2005 391.800.000 -4.26%
2006 521.000.000 24.8%
2007 734.000.000 29.02%
2008 1.093.000.000 32.85%
2009 1.156.000.000 5.45%
2010 1.263.000.000 8.47%
2011 1.259.000.000 -0.32%
2012 1.704.000.000 26.12%
2013 1.683.000.000 -1.25%
2014 673.000.000 -150.07%
2015 1.748.000.000 61.5%
2016 1.425.000.000 -22.67%
2017 1.663.000.000 14.31%
2018 1.380.000.000 -20.51%
2019 1.220.000.000 -13.11%
2020 1.045.000.000 -16.75%
2021 930.000.000 -12.37%
2022 1.136.000.000 18.13%
2023 343.000.000 -231.2%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Getinge AB (publ) Equity
Year Equity Growth
2002 3.158.200.000
2003 3.530.400.000 10.54%
2004 4.220.600.000 16.35%
2005 5.307.400.000 20.48%
2006 5.983.000.000 11.29%
2007 6.598.000.000 9.32%
2008 10.652.000.000 38.06%
2009 12.538.000.000 15.04%
2010 13.223.000.000 5.18%
2011 14.608.000.000 9.48%
2012 15.170.000.000 3.7%
2013 16.531.000.000 8.23%
2014 18.342.000.000 9.87%
2015 19.203.000.000 4.48%
2016 20.508.000.000 6.36%
2017 19.384.000.000 -5.8%
2018 19.655.000.000 1.38%
2019 20.973.000.000 6.28%
2020 21.486.000.000 2.39%
2021 25.176.000.000 14.66%
2022 30.453.000.000 17.33%
2023 32.016.000.000 4.88%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Getinge AB (publ) Assets
Year Assets Growth
2002 9.477.700.000
2003 12.032.300.000 21.23%
2004 12.457.400.000 3.41%
2005 14.533.300.000 14.28%
2006 15.877.000.000 8.46%
2007 22.991.000.000 30.94%
2008 33.032.000.000 30.4%
2009 37.498.000.000 11.91%
2010 34.585.000.000 -8.42%
2011 41.469.000.000 16.6%
2012 42.921.000.000 3.38%
2013 44.303.000.000 3.12%
2014 52.818.000.000 16.12%
2015 53.235.000.000 0.78%
2016 55.211.000.000 3.58%
2017 42.102.000.000 -31.14%
2018 43.352.000.000 2.88%
2019 44.713.000.000 3.04%
2020 45.014.000.000 0.67%
2021 44.555.000.000 -1.03%
2022 52.032.000.000 14.37%
2023 53.540.000.000 2.82%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Getinge AB (publ) Liabilities
Year Liabilities Growth
2002 6.319.500.000
2003 8.501.900.000 25.67%
2004 8.187.800.000 -3.84%
2005 9.152.000.000 10.54%
2006 9.872.000.000 7.29%
2007 16.368.000.000 39.69%
2008 22.356.000.000 26.78%
2009 24.936.000.000 10.35%
2010 21.337.000.000 -16.87%
2011 26.833.000.000 20.48%
2012 27.721.000.000 3.2%
2013 27.743.000.000 0.08%
2014 34.124.000.000 18.7%
2015 33.642.000.000 -1.43%
2016 34.295.000.000 1.9%
2017 22.296.000.000 -53.82%
2018 23.697.000.000 5.91%
2019 23.740.000.000 0.18%
2020 23.528.000.000 -0.9%
2021 19.379.000.000 -21.41%
2022 21.579.000.000 10.2%
2023 21.524.000.000 -0.26%

Getinge AB (publ) Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
111.69
Net Income per Share
8.26
Price to Earning Ratio
27.64x
Price To Sales Ratio
2x
POCF Ratio
23.43
PFCF Ratio
46.05
Price to Book Ratio
1.96
EV to Sales
2.05
EV Over EBITDA
10.02
EV to Operating CashFlow
23.45
EV to FreeCashFlow
47.17
Earnings Yield
0.04
FreeCashFlow Yield
0.02
Market Cap
60,75 Bil.
Enterprise Value
62,22 Bil.
Graham Number
147.15
Graham NetNet
-46.14

Income Statement Metrics

Net Income per Share
8.26
Income Quality
0.77
ROE
0.07
Return On Assets
0.05
Return On Capital Employed
0.1
Net Income per EBT
0.72
EBT Per Ebit
0.86
Ebit per Revenue
0.12
Effective Tax Rate
0.27

Margins

Sales, General, & Administrative to Revenue
0.13
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.45
Operating Profit Margin
0.12
Pretax Profit Margin
0.11
Net Profit Margin
0.08

Dividends

Dividend Yield
0.02
Dividend Yield %
1.86
Payout Ratio
0.52
Dividend Per Share
4.25

Operating Metrics

Operating Cashflow per Share
9.74
Free CashFlow per Share
4.84
Capex to Operating CashFlow
-0.5
Capex to Revenue
-0.04
Capex to Depreciation
-0.61
Return on Invested Capital
0.06
Return on Tangible Assets
0.09
Days Sales Outstanding
0
Days Payables Outstanding
47.71
Days of Inventory on Hand
161.2
Receivables Turnover
0
Payables Turnover
7.65
Inventory Turnover
2.26
Capex per Share
-4.9

Balance Sheet

Cash per Share
19,59
Book Value per Share
116,49
Tangible Book Value per Share
117.55
Shareholders Equity per Share
116.49
Interest Debt per Share
27.19
Debt to Equity
0.21
Debt to Assets
0.13
Net Debt to EBITDA
0.24
Current Ratio
1.93
Tangible Asset Value
4,05 Bil.
Net Current Asset Value
-2,13 Bil.
Invested Capital
0.21
Working Capital
9,33 Bil.
Intangibles to Total Assets
0.52
Average Receivables
0,00 Bil.
Average Payables
2,14 Bil.
Average Inventory
7231000000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Getinge AB (publ) Dividends
Year Dividends Growth
2000 3
2001 3 0%
2002 3 0%
2003 4 0%
2004 1 -200%
2005 2 0%
2006 2 0%
2007 2 50%
2008 2 0%
2009 2 0%
2010 3 0%
2011 3 33.33%
2012 4 0%
2013 4 0%
2014 4 0%
2015 3 -50%
2016 3 0%
2017 2 -100%
2018 2 0%
2019 1 0%
2020 3 66.67%
2021 3 0%
2022 4 25%
2023 4 0%

Getinge AB (publ) Profile

About Getinge AB (publ)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

CEO
Mr. Mattias Perjos M.Sc.
Employee
11.739
Address
Lindholmspiren 7A
Gothenburg, 417 56

Getinge AB (publ) Executives & BODs

Getinge AB (publ) Executives & BODs
# Name Age
1 Mr. Mattias Perjos M.Sc.
Chief Executive Officer, President & Director
70
2 Mr. Lars Sandstrom M.Sc.
Chief Financial Officer
70
3 Ms. Patricia A. Fitch
President of North America Region
70
4 Ms. Anna Romberg MSc Econ
Executive Vice President of Sustainability, Legal & Compliance
70
5 Mr. Magnus Lundback Ph.D.
Executive Vice President of Human Resources
70
6 Mr. Eric Honroth
President of Life Science
70
7 Mr. Lars Mattsson
Head of Investor Relations
70
8 Ms. Elin Frostehav
President of Acute Care Therapies
70
9 Mr. Carsten Blecker
Chief Commercial Officer
70
10 Mr. Stephane Le Roy
President of Surgical Workflows
70

Getinge AB (publ) Competitors

AB SKF (publ) Logo
AB SKF (publ)

SKF-B.ST

(2.5)
Elekta AB (publ) Logo
Elekta AB (publ)

EKTA-B.ST

(2.0)
Alfa Laval AB (publ) Logo
Alfa Laval AB (publ)

ALFA.ST

(2.2)
Sandvik AB (publ) Logo
Sandvik AB (publ)

SAND.ST

(2.8)
Tele2 AB (publ) Logo
Tele2 AB (publ)

TEL2-B.ST

(2.0)